Dimensional Fund Advisors
HOWL icon

Dimensional Fund Advisors’s Werewolf Therapeutics HOWL Stock Holding History

Dimensional Fund Advisors’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-84,607
Closed -$82.4K – 3295
2025
Q1 		$82.4K Sell
84,607
-110,139
-57% -$144K ﹤0.01% 3222
2024
Q4 		$288K Sell
194,746
-63,098
-24% -$129K ﹤0.01% 3117
2024
Q3 		$547K Buy
257,844
+97,267
+61% +$221K ﹤0.01% 3026
2024
Q2 		$392K Buy
160,577
+48,952
+44% +$235K ﹤0.01% 3066
2024
Q1 		$723K Buy
111,625
+48,702
+77% +$284K ﹤0.01% 2978
2023
Q4 		$243K Buy
62,923
+4,795
+8% +$12.2K ﹤0.01% 3165
2023
Q3 		$124K Buy
58,128
+33,515
+136% +$92.4K ﹤0.01% 3290
2023
Q2 		$75.1K Buy
24,613
+11,287
+85% +$31.8K ﹤0.01% 3364
2023
Q1 		$34.6K Sell
13,326
-2,880
-18% -$8.58K ﹤0.01% 3416
2022
Q4 		$33 Sell
16,206
-9,790
-38% -$25.6K ﹤0.01% 3431
2022
Q3 		$117K Buy
+25,996
New +$141K ﹤0.01% 3309

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Dimensional Fund Advisors's HOWL Position: Q2 2025 in Review

Dimensional Fund Advisors sold out of Werewolf Therapeutics (HOWL) in Q2 2025, closing a stake of 84,607 shares — an estimated $82.4K sold.

Dimensional Fund Advisors first reported a position in HOWL in Q3 2022 and held it in 11 quarters. The position peaked at $723K in Q1 2024. 65 funds tracked by Wall St. Rank hold HOWL as of Q2 2025.

  • Dimensional Fund Advisors reported no remaining Werewolf Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 84,607 Werewolf Therapeutics shares in Q2 2025, an estimated $82.4K.
  • Dimensional Fund Advisors first reported a position in Werewolf Therapeutics in Q3 2022 and held it in 11 quarters.
  • Dimensional Fund Advisors's Werewolf Therapeutics position peaked at $723K in Q1 2024.
  • 65 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2025.

Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.